Saving changes...

Done

Error

Allergen Immunotherapy, Today and Tomorrow: Session II. Immunotherapy with Food Allergens

Allergen Immunotherapy, Today and Tomorrow: Session II. Immunotherapy with Food Allergens

Allergen Immunotherapy, Today and Tomorrow: Session II. Immunotherapy with Food Allergens

Cecilia Berin (PhD), Stacie M. Jones (MD),
Cecilia Berin (PhD), Stacie M. Jones (MD),
on behalf of American Academy of Allergy Asthma & Immunology

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 $ 15.00 $ 15.00
$ 15.00 $ 15.00 $ 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 04 Jul 2018
Expiry Date:

Last updated: 22 Aug 2018

Reference: 190545

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This course will summarize the state of the art of allergen immunotherapy for food allergy, including new observations on immunologic changes associated with food allergen immunotherapy and includes a special emphasis on inducing long-term prevention of peanut allergy by early life exposure to allergen. The course will also discuss differences in approaches to immunotherapy for food vs. inhalant allergens.

Objectives

Discuss current and future approaches to allergen immunotherapy for food allergy
Upon completion of this session, participants should be able to discuss current and future approaches to allergen immunotherapy for food allergy.
Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
Upon completion of this session, participants should be able to discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens.
Discuss the durability of immune unresponsiveness induced by allergen immunotherapy or by ingestion of food allergens beginning in infancy
Upon completion of this session, participants should be able to discuss the durability of immune unresponsiveness induced by allergen immunotherapy or by ingestion of food allergens beginning in infancy.
Cecilia Berin (PhD), Stacie M. Jones (MD),

Author Information Play Video Bio

Cecilia Berin (PhD), Stacie M. Jones (MD),
on behalf of American Academy of Allergy Asthma & Immunology

Cecilia Berin, PhD, Icahn School of Medicine at Mount Sinai, New York, NY

Stacie M. Jones, MD, University of Arkansas for Medical Sciences, Little Rock, AR

Gideon Lack, MD, St Thomas' Hospital, London, United Kingdom

Kari C. Nadeau, MD PhD FAAAAI, Stanford University School Medicine, Stanford, CA

Brian P. Vickery, MD FAAAAI, University of North Carolina, Chapel Hill, NC

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 2.50 Credits
  • California Board of Registered Nursing (CBRN)
  • 2.50 Hours

Faculty and Disclosures

Cecilia Berin, PhD

Cecilia Berin, PhD

No Conflict
Stacie M. Jones, MD

Stacie M. Jones, MD

Potential Conflict

DBV Technologies (Ongoing): Grantee
Gideon Lack, MD

Gideon Lack, MD

Potential Conflict

Advisory Board: Merck Sharp and Dohme
Corp
DBV Technologies (Ongoing): Advisory
Board, Stock Options
Kari C. Nadeau, MD PhD FAAAAI

Kari C. Nadeau, MD PhD FAAAAI

No Conflict
Brian P. Vickery, MD FAAAAI

Brian P. Vickery, MD FAAAAI

Potential Conflict

Employer: Aimmune Therapeutics
Title: Senior Medical Director
Company develops treatments for food
allergies.

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error